- by Admin
- 0 Comments
Hepatitis C infection in Children. Professor Manal El Sayed
Summary: The pediatric and adolescent population is often overlooked in surveys and the burden of disease is essentially unknown particularly in countries with high prevalence rates. It is imperative to […]
- by Admin
- 0 Comments
World Hepatitis Summit November 2017
Summary: The World Hepatitis Summit is a public policy three day event bringing together a global audience of civil society groups, WHO and its Member States, patient organisations from the […]
- by Admin
- 0 Comments
All you need to know about HCV diagnosis. Professor Francesco Negro
Most recent and up to date review on HCV diagnosis by Professor Francesco Negro from University Hospital of Geneva, Switzerland. An extensive review on clinical aspects of HCV diagnosis as […]
- by Admin
- 0 Comments
Response Guided Therapy Leads to Complete Cure
Response-guided therapy leads to complete cure after three weeks of all-oral triple-direct acting antiviral regimens in non-cirrhotic chronic hepatitis C genotype 1b Chinese subjects (SODAPI study) This clinical trial […]
- by Admin
- 0 Comments
Treatment Action Group (TAG): an interview with Tracy Swan
A personal perspective on how Treatment Action Groups (TAG) help improve access to life saving drugs for Hepatitis C positive patients, but still more needs to be done. Tracy […]
- by Admin
- 0 Comments
A personal review of a Swedish Hepatitis patient organization “RHC”
Riksföreningen Hepatit C (RHC) is a small organization with fewer than 600 members in the whole country. There are two local organizations, in Stockholm (LHC Stockholm) and in Gothenburg (LHC […]
- by Admin
- 0 Comments
An interview with Dr Jordan Feld, The challenge for hepatitis C drug cost effectiveness
Today, in contrast to Interferon therapy the new direct acting antivirals (DAAs) for HCV can cure patients much faster, with fewer adverse effects, but their cost presents a big challenge […]
- by Admin
- 0 Comments
Novel tools for diagnosis and management of HCV
The diagnostic strategy of HCV infections is usually based on three essential principles: cost, convenience and the ability to link it to HCV treatment. Over the years many diagnostic tests […]
- by Admin
- 0 Comments
The current landscape of HCV treatment
Where does the new AbbVie Viekira Pak regimen fit and what challenges remain? Hepatitis C (HCV) is major global problem however it isn’t homogenous as there is much country to […]
- by Admin
- 0 Comments
Hepatitis C and HIV Co-infection
Hepatitis C (HCV) infection is more common in HIV individuals than in the general population. Early detection allows prompt treatment, reducing the risk of transmission to HCV uninfected individuals. Hepatitis […]
